about
Faulty cardiac repolarization reserve in alternating hemiplegia of childhood broadens the phenotypeAge, Comorbidity, Frailty in Observational and Analytic Studies of Neurological Diseases.Increased prevalence of ECG markers for sudden cardiac arrest in refractory epilepsy.Recurrent Nonconvulsive Status Epilepticus in a Patient with Coffin-Lowry Syndrome.Status epilepticus of inflammatory etiology: a cohort studyGenome-wide Polygenic Burden of Rare Deleterious Variants in Sudden Unexpected Death in Epilepsy.Atypical face shape and genomic structural variants in epilepsy.Retinal nerve fibre layer thinning is associated with drug resistance in epilepsy.Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: A multicenter comparison.Epilepsy, hippocampal sclerosis and febrile seizures linked by common genetic variation around SCN1A.Double seronegative myasthenia gravis with antiphospholipid syndrome: a case report.Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study.Epilepsy as a systemic condition: Link with somatic comorbidities.Therapeutic coma for status epilepticus: Differing practices in a prospective multicenter study.Outcome of seizures in the general population after 25 years: a prospective follow-up, observational cohort study.Cause of death and predictors of mortality in a community-based cohort of people with epilepsy.Status epilepticus: impact of therapeutic coma on outcome.Type 1 diabetes mellitus in people with pharmacoresistant epilepsy: Prevalence and clinical characteristics.FDG-PET hyperactivity pattern in anti-NMDAr encephalitis.Encephalitis with herpes simplex-2 in the cerebrospinal fluid and anti-RI (ANNA-2) antibodies: an infectious or a paraneoplastic syndrome?Long term retention of retigabine in a cohort of people with drug resistant epilepsy.Oral pregabalin as an add-on treatment for status epilepticus.Asystole in alternating hemiplegia with de novo ATP1A3 mutation.[Trouble with vision, hearing and concentration: Susac's syndrome ]Impending status epilepticus and anxiety in a pregnant woman treated with levetiracetam.Yield of Outpatient Sleep EEG for Epileptiform Alterations' Detection in Children.Clinical evolution after a non-reactive hypothermic EEG following cardiac arrest.Recurrent postpartum cerebral sinus vein thrombosis as a presentation of cystathionine-beta-synthase deficiency.A coupled hydrodynamic model of the cardiovascular and cerebrospinal fluid system.Sporadic late-onset nemaline myopathy with MGUS: long-term follow-up after melphalan and SCT.Another cause of vaccine encephalopathy: a case of Angelman syndrome.Rituximab is successful in an HIV-positive patient with MuSK myasthenia gravis.Long-term retention of lacosamide in a large cohort of people with medically refractory epilepsy: A single centre evaluationThe lifelong course of chronic epilepsy: the Chalfont experienceEpilepsy with centrotemporal spikes: A benign condition with potentially serious consequencesLacosamide neurotoxicity associated with concomitant use of sodium channel-blocking antiepileptic drugs: A pharmacodynamic interaction?[Management of the acute and chronic polyradiculoneuropathies][The entrapment neuropathy: a treatable cause of musculoskeletal pain]Ictal bradycardia and asystole: an uncommon cause of syncopeIsolated nuclear facial palsy, a rare variant of pure motor lacunar stroke
P50
Q27303611-9E5C0773-94B6-4206-BD2D-19F458A91A57Q30248768-79BA7916-15F3-4311-841C-DE13F56364DAQ35134455-036D8464-F4E9-4971-B922-5399350CB686Q35905480-417C0AFA-57A4-4D75-BB69-A157C1E88BFBQ35945746-E74AEF1D-1EBB-49A2-B508-DC7095EE648EQ36106276-3F4745A8-4660-4C5C-B908-929BE23C3922Q36315335-1478B6AA-5F5B-4356-82DA-CA1DFC83138BQ36762059-E4E7F5E0-D476-4FBD-903E-9F2375426A24Q36927224-1B82041E-E747-4AE0-A27A-8B83EEA6A900Q37200320-83B36FE0-68F4-4D74-B3F9-AA84D06B95C9Q37566657-B09DCBFC-09ED-4F2B-975F-E094B3BEEA18Q37641223-B2DC7B3D-B604-4A46-8610-7956E93872EDQ38749358-84735E72-7703-4954-88FB-883251123711Q39354540-63D6E76B-A52E-4574-82B0-79FDCA42B61CQ40093559-19E1A1AA-81CA-4027-84EA-D28B14855A2CQ40973567-2FA4053D-AB22-4814-A059-43D25337DB5EQ41475532-51714FF9-CA2F-46AC-A936-604FD66D6813Q41536744-8EA935CE-AF42-479B-8A9D-89CEF3DFD0D9Q42495984-278C376E-40F1-4E7C-9FB9-911D4A04D4E8Q42584225-AB27ADB9-166C-44C2-9A54-2D7D02675868Q42679816-97208A37-EAC2-49EF-8FE8-5C0555E1AEFEQ43021340-2F02AB94-1DC4-473B-9C92-2F8049E3573AQ43412414-76B21DAF-F00E-4398-88A9-C07F7D0B1770Q46481875-7FC6FA01-3B7E-4993-BAA2-BAD94C329189Q46511636-AC1D00BD-178D-4C93-BCC3-88B01030F609Q47919127-A12DC68B-396F-4461-821D-6121267E80C8Q48418736-ACF7B179-1D0B-4823-8310-D2A8BA357DCCQ50233431-DE4963DF-2A9D-40D3-B23D-ACEBCD99BB68Q51440567-40DF2AAB-64C7-41C5-8207-E50C7FC16D8AQ51685458-012BE18E-835D-4967-9758-07BCAB385AE4Q51814103-C1A2B1AC-A376-48D1-A7C3-1494AF3975C6Q54171844-CC15E14B-A062-4995-B723-8572C9777B3DQ58449751-CD594278-A16C-4C4A-8483-1E36AC6E46D2Q58449759-64CCC6DC-7E80-448E-90EF-1D78A9B802D9Q58449796-E46FA339-2BAE-4941-8CB5-4A58AC905D77Q58449801-94ECBCD8-C23E-4C80-9DE5-70B97CBE259FQ80468294-2F42D1BB-6021-4F49-88A8-EB873A111280Q80468297-38A4AF19-95B0-463A-9AEB-0C2F245A8021Q80483733-7795F36D-62E1-41C1-86EF-E8EEEFED8338Q80666544-3490C94A-6F9B-4898-BA0F-615D2D0AEF6F
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jan Novy
@ast
Jan Novy
@en
Jan Novy
@es
Jan Novy
@nl
Jan Novy
@sl
type
label
Jan Novy
@ast
Jan Novy
@en
Jan Novy
@es
Jan Novy
@nl
Jan Novy
@sl
prefLabel
Jan Novy
@ast
Jan Novy
@en
Jan Novy
@es
Jan Novy
@nl
Jan Novy
@sl
P106
P21
P31
P496
0000-0002-6862-7083